STALICLA is a precision molecular neuroscience clinical stage biotech company, advancing the first precision medicine platform (DEPI) for patients with neurodevelopmental disorders (NDDs) and neuropsychiatric disorders
STALICLA is a precision molecular neuroscience clinical stage biotech company, advancing the first precision medicine platform (DEPI) for patients with neurodevelopmental disorders (NDDs) and neuropsychiatric disorders. The company focuses on personalized treatments for brain disorders, leveraging multiomics, patient data, and AI to match patients with the right drug treatments.